October 1, 2025 · Form 4 insider transaction
Fox Jonathan C bought 728 shares of EWTX at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Consists of restricted stock units, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. (the "Issuer") common stock, granted and released to the reporting person on October 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the Issuer's Outside Director Compensation Policy, as amended.